• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

METTL3介导的CYP2C19 mRNA甲基化可能会加重缺血性中风患者对氯吡格雷的抵抗。

METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients.

作者信息

Tan Quandan, Yang Le, Yuan Shanshan, Zheng Danni, Lin Yapeng, Chen Kejie, He Ying, Chen Shuntian, Hao Junli, Dai Jin, He Song, Mao Fengkai, Leng Xinyi, Jiang Haisong, Yang Jie

机构信息

Department of Neurology, The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.

Department of Neurology, The Second Affiliated Hospital of Chengdu Medical College, Chengdu, China.

出版信息

Open Med (Wars). 2024 Feb 7;19(1):20240899. doi: 10.1515/med-2024-0899. eCollection 2024.

DOI:10.1515/med-2024-0899
PMID:38463525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10921439/
Abstract

BACKGROUND

N6-methyladenosine (mA) is the most frequently occurring interior modification in eukaryotic messenger RNA (mRNA), and abnormal mRNA modifications can affect many biological processes. However, mA's effect on the metabolism of antiplatelet drugs for the prevention of ischemic stroke (IS) remains largely unclear.

METHODS

We analyzed the mA enzymes and mA methylation in peripheral blood samples of IS patients with/without clopidogrel resistance (CR), and the peripheral blood and liver of rat models with/without CR. We also compared the effect of mA methylation on the expression of the drug-metabolizing enzymes (CYP2C19 and CYP2C6v1) in CR and non-CR samples.

RESULTS

Methyltransferase-like 3 (METTL3), an mA enzyme, was highly expressed in the peripheral blood of patients with CR, and in both the peripheral blood and liver of rats with CR. This enzyme targets CYP2C19 or CYP2C6v1 mRNA through mA methylation, resulting in low expression of CYP2C19 or CYP2C6v1 mRNA. Consequently, this leads to decreased clopidogrel metabolism and CR.

CONCLUSION

The METTL3-mediated methylation of CYP2C19 mRNA may aggravate CR in IS patients.

摘要

背景

N6-甲基腺苷（mA）是真核生物信使核糖核酸（mRNA）中最常见的内部修饰，异常的mRNA修饰可影响许多生物学过程。然而，mA对用于预防缺血性中风（IS）的抗血小板药物代谢的影响仍不清楚。

方法

我们分析了有/无氯吡格雷抵抗（CR）的IS患者外周血样本以及有/无CR的大鼠模型的外周血和肝脏中的mA酶和mA甲基化情况。我们还比较了mA甲基化对CR和非CR样本中药物代谢酶（CYP2C19和CYP2C6v1）表达的影响。

结果

mA酶样甲基转移酶3（METTL3）在CR患者的外周血以及CR大鼠的外周血和肝脏中均高表达。该酶通过mA甲基化靶向CYP2C19或CYP2C6v1 mRNA，导致CYP2C19或CYP2C6v1 mRNA表达降低。因此，这导致氯吡格雷代谢减少和CR。

结论

METTL3介导的CYP2C19 mRNA甲基化可能会加重IS患者的CR。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/c58f4e7f5cb4/j_med-2024-0899-fig007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/d1eb31adc234/j_med-2024-0899-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/bc97b0b1e017/j_med-2024-0899-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/123f5c5e0cca/j_med-2024-0899-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/aa29451e0264/j_med-2024-0899-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/65d81bd5b006/j_med-2024-0899-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/58f2f9c3defd/j_med-2024-0899-fig006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/c58f4e7f5cb4/j_med-2024-0899-fig007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/d1eb31adc234/j_med-2024-0899-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/bc97b0b1e017/j_med-2024-0899-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/123f5c5e0cca/j_med-2024-0899-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/aa29451e0264/j_med-2024-0899-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/65d81bd5b006/j_med-2024-0899-fig005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/58f2f9c3defd/j_med-2024-0899-fig006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5136/10921439/c58f4e7f5cb4/j_med-2024-0899-fig007.jpg

相似文献

1
METTL3-mediated methylation of CYP2C19 mRNA may aggravate clopidogrel resistance in ischemic stroke patients.METTL3介导的CYP2C19 mRNA甲基化可能会加重缺血性中风患者对氯吡格雷的抵抗。
Open Med (Wars). 2024 Feb 7;19(1):20240899. doi: 10.1515/med-2024-0899. eCollection 2024.
2
METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.METTL3 通过 Fasn mRNA 的 N6-甲基腺苷修饰抑制肝胰岛素敏感性并促进脂肪酸代谢。
Biochem Biophys Res Commun. 2019 Oct 8;518(1):120-126. doi: 10.1016/j.bbrc.2019.08.018. Epub 2019 Aug 10.
3
METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.METTL3 介导的 N6-甲基腺苷甲基化修饰改变 Foxp3 mRNA 水平，并影响哮喘患者外周血 Treg 细胞比例。
Ann Clin Lab Sci. 2022 Nov;52(6):884-894.
4
Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.CYP3A4、NR1I2、CYP2C19和P2RY12基因多态性与中国缺血性脑卒中患者氯吡格雷抵抗的相关性
Acta Pharmacol Sin. 2016 Jul;37(7):882-8. doi: 10.1038/aps.2016.41. Epub 2016 May 2.
5
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China.中国冠心病和缺血性脑卒中患者 CYP2C19 多态性与氯吡格雷抵抗的关系。
Genet Res (Camb). 2022 Oct 21;2022:1901256. doi: 10.1155/2022/1901256. eCollection 2022.
6
Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance.体重、CYP2C19 和 P2Y12 受体多态性与阿司匹林不耐受的中国缺血性脑卒中患者氯吡格雷抵抗相关。
Eur J Clin Pharmacol. 2020 Nov;76(11):1517-1527. doi: 10.1007/s00228-020-02946-5. Epub 2020 Jul 6.
7
METTL3-mA-Rubicon axis inhibits autophagy in nonalcoholic fatty liver disease.METTL3-mA-Rubicon 轴抑制非酒精性脂肪性肝病中的自噬。
Mol Ther. 2022 Feb 2;30(2):932-946. doi: 10.1016/j.ymthe.2021.09.016. Epub 2021 Sep 20.
8
Identification of Key Genes Mediated by N6-Methyladenosine Methyltransferase METTL3 in Ischemic Stroke via Bioinformatics Analysis and Experiments.通过生物信息学分析和实验鉴定N6-甲基腺苷甲基转移酶METTL3介导的缺血性中风关键基因
Mol Biotechnol. 2025 Jan;67(1):160-174. doi: 10.1007/s12033-023-00991-w. Epub 2023 Dec 22.
9
Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.氯吡格雷和阿司匹林联合治疗可预防携带CYP2C19*2功能降低等位基因的缺血性中风患者早期神经功能恶化。
Eur J Clin Pharmacol. 2018 Sep;74(9):1131-1140. doi: 10.1007/s00228-018-2468-7. Epub 2018 May 26.
10
METTL3 plays a crucial function in multiple biological processes.METTL3 在多种生物过程中发挥着关键作用。
Acta Histochem. 2022 Aug;124(6):151916. doi: 10.1016/j.acthis.2022.151916. Epub 2022 Jun 22.

本文引用的文献

1
European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack.欧洲卒中组织（ESO）关于缺血性卒中或短暂性脑缺血发作后长期二级预防的药物干预指南。
Eur Stroke J. 2022 Sep;7(3):I-II. doi: 10.1177/23969873221100032. Epub 2022 Jun 3.
2
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.N6-甲基腺苷（m6A）修饰与环状 RNA 之间的相互调控在癌症中的作用：对治疗抵抗性的影响。
Mol Cancer. 2022 Jul 18;21(1):148. doi: 10.1186/s12943-022-01620-x.
3
Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.
m6A 甲基化在心脏代谢疾病中的新兴作用和机制。
Cells. 2022 Mar 24;11(7):1101. doi: 10.3390/cells11071101.
4
Harmonizing model organism data in the Alliance of Genome Resources.在基因组资源联盟中协调模式生物数据。
Genetics. 2022 Apr 4;220(4). doi: 10.1093/genetics/iyac022.
5
Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.N6-甲基腺苷（m6A）修饰与环状RNA在癌症中的相互作用研究进展
Mol Ther Nucleic Acids. 2022 Jan 21;27:947-955. doi: 10.1016/j.omtn.2022.01.013. eCollection 2022 Mar 8.
6
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新：美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
7
N-methyladenosine modification regulates imatinib resistance of gastrointestinal stromal tumor by enhancing the expression of multidrug transporter MRP1.N6-甲基腺苷修饰通过增强多药转运蛋白 MRP1 的表达来调节胃肠道间质瘤对伊马替尼的耐药性。
Cancer Lett. 2022 Apr 1;530:85-99. doi: 10.1016/j.canlet.2022.01.008. Epub 2022 Jan 13.
8
World Stroke Organization (WSO): Global Stroke Fact Sheet 2022.世界卒中组织（WSO）：全球卒中状况 2022 概要。
Int J Stroke. 2022 Jan;17(1):18-29. doi: 10.1177/17474930211065917.
9
Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions.全球卒中流行病学和急性缺血性卒中干预措施的可及性。
Neurology. 2021 Nov 16;97(20 Suppl 2):S6-S16. doi: 10.1212/WNL.0000000000012781.
10
Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by mA methylation promotes disease progression and sorafenib resistance.长链非编码 RNA NIFK-AS1 在肝癌中的 mA 甲基化上调促进疾病进展和索拉非尼耐药。
Hum Cell. 2021 Nov;34(6):1800-1811. doi: 10.1007/s13577-021-00587-z. Epub 2021 Aug 10.